Payment overview · 2025
General Payments
$27.20
1 reported records · 1 companies
Healthcare provider profile · identity verified
John Mark Bennett, MD
Allopathic & Osteopathic Physicians|Family Medicine · FOREST CITY, NC · NPI 1033189717
Verified facts
What the public records show
CMS Open Payments records show John Mark Bennett, MD received $27.20 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $27.20 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $27.20 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $27.20 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 805 | 192 |
| Atorvastatin Calcium | Atorvastatin Calcium | 771 | 206 |
| Pantoprazole Sodium | Pantoprazole Sodium | 453 | 106 |
| Levothyroxine Sodium | Levothyroxine Sodium | 441 | 96 |
| Lisinopril | Lisinopril | 422 | 111 |
| Tamsulosin Hcl | Tamsulosin Hcl | 344 | 81 |
| Omeprazole | Omeprazole | 341 | 85 |
| Lorazepam | Lorazepam | 287 | 60 |
| Montelukast Sodium | Montelukast Sodium | 278 | 74 |
| Losartan Potassium | Losartan Potassium | 273 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 267 | 68 |
| Metformin Hcl | Metformin Hcl | 259 | 67 |
| Tramadol Hcl | Tramadol Hcl | 258 | 71 |
| Clonazepam | Clonazepam | 245 | 42 |
| Trazodone Hcl | Trazodone Hcl | 215 | 47 |
| Alendronate Sodium | Alendronate Sodium | 211 | 46 |
| Eliquis | Apixaban | 210 | 35 |
| Gabapentin | Gabapentin | 208 | 54 |
| Furosemide | Furosemide | 191 | 62 |
| Duloxetine Hcl | Duloxetine Hcl | 178 | 30 |
| Meloxicam | Meloxicam | 177 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 176 | 43 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 173 | 46 |
| Glipizide Er | Glipizide | 167 | 36 |
| Simvastatin | Simvastatin | 166 | 38 |
| Fluticasone Propionate | Fluticasone Propionate | 163 | 71 |
| Hydrochlorothiazide | Hydrochlorothiazide | 159 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 158 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 158 | 28 |
| Potassium Chloride | Potassium Chloride | 148 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 144 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 140 | 32 |
| Donepezil Hcl | Donepezil Hcl | 140 | 22 |
| Indapamide | Indapamide | 128 | 30 |
| Carvedilol | Carvedilol | 126 | 31 |
| Allopurinol | Allopurinol | 120 | 31 |
| Sertraline Hcl | Sertraline Hcl | 118 | 29 |
| Alprazolam | Alprazolam | 116 | 20 |
| Pregabalin | Pregabalin | 115 | 25 |
| Famotidine | Famotidine | 112 | 34 |
| Prednisone | Prednisone | 103 | 71 |
| Mirtazapine | Mirtazapine | 100 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 99 | 41 |
| Fenofibrate | Fenofibrate | 95 | 27 |
| Tizanidine Hcl | Tizanidine Hcl | 95 | 24 |
| Buspirone Hcl | Buspirone Hcl | 89 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 89 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 82 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 81 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 22 |
| Ondansetron Odt | Ondansetron | 75 | 18 |
| Bupropion Hcl Sr | Bupropion Hcl | 73 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 73 | 23 |
| Farxiga | Dapagliflozin Propanediol | 72 | 11 |
| Primidone | Primidone | 72 | 13 |
| Temazepam | Temazepam | 71 | 11 |
| Xarelto | Rivaroxaban | 70 | 14 |
| Ozempic | Semaglutide | 67 | 13 |
| Warfarin Sodium | Warfarin Sodium | 67 | 16 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 66 | 14 |
| Aripiprazole | Aripiprazole | 65 | 13 |
| Doxepin Hcl | Doxepin Hcl | 64 | 13 |
| Spironolactone | Spironolactone | 64 | 19 |
| Azithromycin | Azithromycin | 63 | 60 |
| Celecoxib | Celecoxib | 63 | 21 |
| Memantine Hcl | Memantine Hcl | 61 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 60 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | 13 |
| Jardiance | Empagliflozin | 59 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 59 | 27 |
| Meclizine Hcl | Meclizine Hcl | 57 | 21 |
| Ezetimibe | Ezetimibe | 55 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 55 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | 14 |
| Finasteride | Finasteride | 51 | 11 |
| Nitroglycerin | Nitroglycerin | 51 | 20 |
| Bumetanide | Bumetanide | 49 | 12 |
| Glimepiride | Glimepiride | 49 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 48 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | 14 |
| Atenolol | Atenolol | 46 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 46 | 11 |
| Trulicity | Dulaglutide | 46 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 43 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 43 | 12 |
| Amoxicillin | Amoxicillin | 42 | 38 |
| Breo Ellipta | Fluticasone/Vilanterol | 41 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 32 |
| Estradiol | Estradiol | 40 | 17 |
| Myrbetriq | Mirabegron | 39 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 39 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 38 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 35 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | suppressed |
| Telmisartan | Telmisartan | 34 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 34 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 33 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | suppressed |
| Topiramate | Topiramate | 32 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 30 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 28 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 27 | suppressed |
| Invokana | Canagliflozin | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Ketoconazole | Ketoconazole | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 19 |
| Testosterone | Testosterone | 22 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Cefdinir | Cefdinir | 21 | 17 |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 17 |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | 12 |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Klor-Con M15 | Potassium Chloride | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $27.20 · 1 records | Amgen Inc. | KRYSTEXXA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error